7 results match your criteria: "Asklepieio General Hospital[Affiliation]"

Article Synopsis
  • Researchers studied how different immune endotypes affect responses to anakinra treatment in patients with severe pneumonia caused by COVID-19 during the SAVE-MORE trial.
  • The study found that many patients transitioned between immune endotypes during treatment, with anakinra helping those with the adaptive endotype to maintain better outcomes.
  • Anakinra also reduced the risk of severe respiratory failure in patients with a coagulopathic endotype compared to placebo, indicating its potential benefits in managing sepsis-related conditions.
View Article and Find Full Text PDF

Objectives: Elevated concentrations of soluble urokinase plasminogen activator receptor (suPAR) predict progression to severe respiratory failure (SRF) or death among patients with COVID-19 pneumonia and guide early anakinra treatment. As suPAR testing may not be routinely available in every health-care setting, alternative biomarkers are needed. We investigated the performance of C-reactive protein (CRP), interferon gamma-induced protein-10 (IP-10) and TNF-related apoptosis-inducing ligand (TRAIL) for predicting SRF or death in COVID-19.

View Article and Find Full Text PDF

Objective: The proportion of SLE patients with residual disease activity in routine settings is variable. We assessed disease activity state in patients during their most recent visit, and whether patients with residual activity were offered therapy intensification.

Methods: Cross-sectional study of consecutive lupus patients in three tertiary centers.

View Article and Find Full Text PDF

Early increase of soluble urokinase plasminogen activator receptor (suPAR) serum levels is indicative of increased risk of progression of coronavirus disease 2019 (COVID-19) to respiratory failure. The SAVE-MORE double-blind, randomized controlled trial evaluated the efficacy and safety of anakinra, an IL-1α/β inhibitor, in 594 patients with COVID-19 at risk of progressing to respiratory failure as identified by plasma suPAR ≥6 ng ml, 85.9% (n = 510) of whom were receiving dexamethasone.

View Article and Find Full Text PDF

Non-occlusive colonic ischaemia is a recognized albeit rare entity related to low blood flow within the visceral circulation and in most reported cases the right colon was affected. This is the second case report in the literature of extensive colonic necrosis following cardiac arrest and cardiopulmonary resuscitation (CPR). A 83-year-old Caucasian woman was admitted to our hospital due to a low energy hip fracture.

View Article and Find Full Text PDF